Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Equity: 2021-2025

Historic Return on Equity for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to -0.38%.

  • Journey Medical's Return on Equity rose 127.00% to -0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.38%, marking a year-over-year increase of 127.00%. This contributed to the annual value of -0.73% for FY2024, which is 52.00% down from last year.
  • Latest data reveals that Journey Medical reported Return on Equity of -0.38% as of Q3 2025, which was up 10.44% from -0.42% recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Return on Equity registered a high of 0.07% during Q2 2024, and its lowest value of -10.46% during Q2 2023.
  • For the 3-year period, Journey Medical's Return on Equity averaged around -1.75%, with its median value being -0.42% (2025).
  • Per our database at Business Quant, Journey Medical's Return on Equity plummeted by 938bps in 2023 and then surged by 1,053bps in 2024.
  • Journey Medical's Return on Equity (Quarterly) stood at -2.90% in 2021, then soared by 153bps to -1.37% in 2022, then surged by 117bps to -0.20% in 2023, then crashed by 74bps to -0.94% in 2024, then skyrocketed by 127bps to -0.38% in 2025.
  • Its last three reported values are -0.38% in Q3 2025, -0.42% for Q2 2025, and -0.40% during Q1 2025.